Overview
- 76 inspections across 56 sites are on record.
- 104 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2013-11-25.
At a glance
Inspections
76
Sites
56
Observations
104
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| LTS Lohmann Therapy Systems Corp. | 25 Nov 2013 | Human Drugs | |
| Amneal Pharmaceuticals LLC | 17 Oct 2013 | Human Drugs | |
| Cyalume Specialty Products | 27 Sep 2013 | Human Drugs | |
| Pfizer, Inc. | 5 Sep 2013 | Human Drugs | |
| Novel Laboratories, Inc. d.b.a Lupin Somerset | 26 Aug 2013 | Human Drugs | View 483 → |
Sites inspected
LTS Lohmann Therapy Systems Corp.West Caldwell, United States1 insp.
Amneal Pharmaceuticals LLCBranchburg, United States1 insp.
Cyalume Specialty ProductsBound Brook, United States1 insp.
Pfizer, Inc.Parsippany, United States1 insp.
Novel Laboratories, Inc. d.b.a Lupin SomersetSomerset, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael R Klapal4 shared
Charles Chacko4 shared
Erin D Mccaffery4 shared
Stephen J Mottola3 shared
Barbara J Wilimczyk-Macri3 shared
Liatte Krueger3 shared
Alberto A Viciedo3 shared
Nikki S Ramirez2 shared
Melba T Rivera Clavell2 shared
Michael Serrano2 shared
Full investigator report
Get the verbatim findings behind Douglas C Kovacs' 104 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site